Skip to main content

Table 1 Patient characteristics and degree of anemia at enrollment

From: Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania

Variables

Normal

n (%)

Mild anemiaa

n (%)

Moderate anemiab

n (%)

Severe anemiac

n (%)

P

All (n = 838)

189 (22.6)

269 (32.1)

238 (28.4)

142 (16.9)

 

Gender

    

0.046

   Female

115 (21.1)

165 (30.3)

171 (31.4)

94 (17.2)

 

   Male

74 (25.2)

104 (35.5)

67 (22.9)

48 (16.4)

 

Age (years)

    

0.726

   <30

40 (20.1)

61 (30.7)

61 (30.7)

37 (18.6)

 

   30-39

75 (22.1)

106 (31.3)

98 (28.9)

60 (17.7)

 

   ≥40

74 (24.7)

102 (34.0)

79 (26.3)

45 (15.0)

 

AIDSd

    

<0.001

   Yes

48 (12.0)

109 (27.3)

146 (36.6)

96 (24.1)

 

   No

141 (32.1)

160 (36.4)

92 (21.0)

46 (10.5)

 

Tuberculosise

    

0.001

   Yes

9 (9.2)

34 (34.7)

28 (28.6)

27 (27.5)

 

   No

180 (24.3)

235 (31.8)

210 (28.4)

115 (15.5)

 

BMI (kg/m2)f

    

<0.001

   <16

17 (8.8)

49 (25.4)

67 (34.7)

60 (31.1)

 

   16-18.4

46 (19.7)

74 (31.8)

76 (32.6)

37 (15.9)

 

   ≥18.5

118 (33.5)

134 (38.1)

76 (21.6)

24 (6.8)

 

MCV (fL)

    

<0.001

   <80

36 (11.7)

90 (29.2)

116 (37.7)

66 (21.4)

 

   ≥80

153 (28.9)

179 (33.8)

122 (23.0)

76 (14.3)

 

MCH (pg)

    

<0.001

   <26

35 (10.3)

95 (27.9)

130 (38.1)

81 (23.7)

 

   ≥26

154 (31.0)

174 (35.0)

108 (21.7)

61 (12.3)

 
  1. aHemoglobin 10-12 g/dL (10-13 g/dL for men). bHemoglobin 8-10 g/dL. cHemoglobin <8 g/dL. dWorld Health Organization clinical stage 4. eOn tuberculosis treatment at enrollment. f60 values missing (n = 778).
  2. BMI, body mass index; MCV, mean cell volume; MCH, mean corpuscular hemoglobin.